Market research
600521.SHG Zhejiang Huahai Pharmaceutical Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 23B
- P/E ratio
- 36.6
- Analyst target
- 17.8667
- Dividend yield
- 0.6%
- Beta
- 0.13
Community
Investor discussion
1 comment
Sign in to join the 600521.SHG discussion.
5 years, 5 months ago
Zhejiang Huahai Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 25.8% below its 200 day moving average.
From a valuation standpoint, the stock is 39.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.8.
Zhejiang Huahai Pharmaceutical Co., Ltd's total revenue rose by 15.2% to $2B since the same quarter in the previous year.
Its net income has increased by 48.1% to $262M since the same quarter in the previous year.
Finally, its free cash flow fell by 70.2% to $133M since the same quarter in the previous year.
Based on the above factors, Zhejiang Huahai Pharmaceutical Co., Ltd gets an overall score of 3/5.